To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Liposomal bupivacaine vs Ranawat suspension injection for postoperative pain after TKA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2016

Liposomal bupivacaine vs Ranawat suspension injection for postoperative pain after TKA

Vol: 5| Issue: 8| Number:37| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Periarticular Injection After Total Knee Arthroplasty Using Liposomal Bupivacaine vs a Modified Ranawat Suspension: A Prospective, Randomized Study

J Arthroplasty. 2016 Mar;31(3):633-6.

Contributing Authors:
PN Collis AM Hunter MD Vaughn LY Carreon J Huang A Malkani

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

105 patients scheduled to undergo total knee arthroplasty were randomized to receive either liposomal bupivacaine or modified Ranawat suspension periarticular injection, for the purpose of determining if either injection treatment was associated with significantly improved postoperative pain, narcotic requirement and functional restoration/improvement. Results demonstrated comparable pain and clin...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.